D.E. Shaw & Co’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,212
| Closed | -$27K | – | 4070 |
|
|
2022
Q2 | $27K | Sell |
8,212
-1,609
| -16% | -$5.29K | ﹤0.01% | 3773 |
|
|
2022
Q1 | $43K | Sell |
9,821
-38,518
| -80% | -$169K | ﹤0.01% | 3921 |
|
|
2021
Q4 | $459K | Buy |
48,339
+2,735
| +6% | +$26K | ﹤0.01% | 3127 |
|
|
2021
Q3 | $771K | Sell |
45,604
-17,515
| -28% | -$296K | ﹤0.01% | 2620 |
|
|
2021
Q2 | $1.76M | Buy |
63,119
+60,379
| +2,204% | +$1.68M | ﹤0.01% | 2167 |
|
|
2021
Q1 | $61K | Sell |
2,740
-68
| -2% | -$1.51K | ﹤0.01% | 2894 |
|
|
2020
Q4 | $41K | Buy |
+2,808
| New | +$41K | ﹤0.01% | 2678 |
|
|
2020
Q2 | – | Sell |
-3,536
| Closed | -$67K | – | 2765 |
|
|
2020
Q1 | $67K | Buy |
3,536
+1,042
| +42% | +$19.7K | ﹤0.01% | 2577 |
|
|
2019
Q4 | $72K | Buy |
+2,494
| New | +$72K | ﹤0.01% | 2580 |
|
|
2019
Q3 | – | Sell |
-1,479
| Closed | -$117K | – | 2680 |
|
|
2019
Q2 | $117K | Buy |
+1,479
| New | +$117K | ﹤0.01% | 2475 |
|
|
2019
Q1 | – | Sell |
-1,021
| Closed | -$57K | – | 2659 |
|
|
2018
Q4 | $57K | Buy |
+1,021
| New | +$57K | ﹤0.01% | 2492 |
|